Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Learn which credit cards provide the best reward points and how to maximize their value. Enhance your rewards strategy.
28,145 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Plug Power recently beat quarterly estimates, but that isn’t a guarantee the stock is safe to buy. This guide breaks ...
Today’s energy-focused market action shows how volatile solar stocks can be when short-seller whispers collide with b...
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
Novo Nordisk stock faced renewed selling pressure this week as investors weighed trial results and government-driven ...
A dramatic drop can set the stage for a smart rebound. This guide explains how to analyze a growth stock down right, ...
Realty Income anchors retiree portfolios with a steady 5.3% yield, supported by robust AFFO coverage and a resilient ...
When an insider doubles down on a falling stock, investors sit up and take notice. This article breaks down what it c...
MercadoLibre reports 40% year-over-year growth fueled by fintech expansion and a resilient e-commerce network in Lati...
Three well-known retailers face rising pressure as consumer spending cools and online competition intensifies. These ...
Goldman Sachs warns that real income per worker is dipping despite a robust job market, signaling a hidden squeeze on...
As CleanSpark gears up for its 2026 earnings season, investors wonder how mining economics, energy initiatives, and c...